Sava Infond D.O.O. Dexcom Inc Transaction History
Sava Infond D.O.O.
- $640 Billion
- Q2 2025
A detailed history of Sava Infond D.O.O. transactions in Dexcom Inc stock. As of the latest transaction made, Sava Infond D.O.O. holds 6,100 shares of DXCM stock, worth $481,046. This represents 0.08% of its overall portfolio holdings.
Number of Shares
6,100
Previous 6,100
-0.0%
Holding current value
$481,046
Previous $417 Million
27.82%
% of portfolio
0.08%
Previous 0.08%
Shares
1 transactions
Others Institutions Holding DXCM
# of Institutions
1,102Shares Held
370MCall Options Held
5.74MPut Options Held
4.85M-
Vanguard Group Inc Valley Forge, PA47.5MShares$3.74 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.72 Billion0.09% of portfolio
-
Baillie Gifford & CO16.7MShares$1.32 Billion1.14% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.32 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA12MShares$949 Million0.19% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $30.5B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...